|
1
|
Chinese Society of Hepatology and Chinese
Society of Infectious Diseases, Chinese Medical Association. The
guideline of prevention and treatment for chronic hepatitis B (2010
version). Zhonghua Gan Zang Bing Za Zhi. 19:13–24. 2011.(In
Chinese).
|
|
2
|
Levrero M, Pollicino T, Petersen J, et al:
Control of cccDNA function in hepatitis B virus infection. J
Hepatol. 51:581–592. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Boni C, Fisicaro P, Valdatta C, et al:
Characterization of hepatitis B virus (HBV)-specific T-cell
dysfunction in chronic HBV infection. J Virol. 81:4215–4225. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Peng G, Li S, Wu W, et al: Circulating
CD4+ CD25+ regulatory T cells correlate with chronic hepatitis B
infection. Immunology. 123:1357–1365. 2008. View Article : Google Scholar
|
|
5
|
Yang G, Liu A, Xie Q, et al: Association
of CD4+CD25+Foxp3+ regulatory T cells with chronic activity and
viral clearance in patients with hepatitis B. Int Immunol.
19:133–140. 2007. View Article : Google Scholar
|
|
6
|
Xu D, Fu J, Jin L, et al: Circulating and
liver resident CD4+CD25+ regulatory T cells actively influence the
antiviral immune response and disease progression in patients with
hepatitis B. J Immunol. 177:739–747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kondo Y, Kobayashi K, Ueno Y, et al:
Mechanism of T cell hyporesponsiveness to HBcAg is associated with
regulatory T cells in chronic hepatitis B. World J Gastroenterol.
12:4310–4317. 2006.PubMed/NCBI
|
|
8
|
Xu D, Fu J, Jin L, Zhang H, et al:
Circulating and liver resident CD4+CD25+
regulatory T cells actively influence the antiviral immune response
and disease progression in patients with hepatitis B. J Immunol.
177:739–747. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Stoop JN, van der Molen RG, Baan CC, et
al: Regulatory T cells contribute to the impaired immune response
in patients with chronic hepatitis B virus infection. Hepatology.
41:771–778. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Curiel TJ: Tregs and rethinking cancer
immunotherapy. J Clin Invest. 117:1167–1174. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ruter J, Barnett BG, Kryczek I, et al:
Altering regulatory T cell function in cancer immunotherapy: a
novel means to boost the efficacy of cancer vaccines. Frontier
Biosci (Landmark Ed). 14:1761–1770. 2009. View Article : Google Scholar
|
|
12
|
Juang CM, Hung CF, Yeh JY, et al:
Regulatory T cells: potential target in anticancer immunotherapy.
Taiwan J Obstet Gynecol. 46:215–221. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Greten TF, Manns MP and Korangy F:
Immunotherapy of hepatocellular carcinoma. J Hepatol. 45:868–878.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Romagnani S: T cell subpopulations. Chem
Immunol Allergy. 100:155–164. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Hall BM, Verma ND, Tran GT and Hodginkson
SJ: Distinct regulatory CD4+T cell subsets; differences between
naïve and antigen specific T regulatory cells. Curr Opin Immunol.
23:641–647. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Bettelli E, Carrier Y, Gao W, et al:
Reciprocal developmental pathways for generation of pathogenic
effector Thl7 and regulatory T cells. Nature. 441:235–238. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhang Y, Ma D, Zhang Y, et al: The
imbalance of Th17/Treg in patients with uterine cervical cancer.
Clin Clim Acta. 412:894–900. 2011. View Article : Google Scholar
|
|
18
|
Zhang B, Rong G, Wei H, et al: The
prevalence of Th17 cells in patients with gastric cancer. Biochem
Biophys Res Commun. 374:533–537. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Miyahara Y, Odunsi K, Chen W, et al:
Generation and regulation of human CD4+ IL-17-producing
T cells in ovarian cancer. Proc Natl Acad Sci USA. 105:15505–15510.
2008. View Article : Google Scholar
|
|
20
|
Le Gouvello S, Bastuji-Garin S, Aloulou N,
et al: High prevalence of Foxp3 and IL17 in MMR-proficient
colorectal carcinomas. Gut. 57:772–779. 2008. View Article : Google Scholar
|
|
21
|
Alatrakchi N and Koziel M: Regulatory T
cells and viral liver disease. J Viral Hepat. 16:223–229. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen Z, Ding J, Pang N, et al: The
Th17/Treg balance and the expression of related cytokines in Uygur
cervical cancer patients. Diagn Pathol. 8:612013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Yu XL, Guo R, Ming D, et al: Ratios of
regulatory T cells/T-helper 17 cells and tranforming growth
factor-β1/interleukin-17 to be associated with the development of
hepatitis B virus-associated liver cirrhosis. J Gastronenterol
Hepatol. 29:1065–1072. 2014. View Article : Google Scholar
|
|
24
|
Zhang GL, Xie DY, Lin BL, et al: Imbalance
of interleukin-17-producing CD4 T cells/regulatory T cells axis
occurs in remission stage of patients with hepatitis B
virus-related acute-on-chronic liver failure. J Gastronenterol
Hepatol. 28:513–521. 2013. View Article : Google Scholar
|
|
25
|
Li Y, Tang L and Hou J: Role of
interleukin-21 in HBV infection: friend or foe? Cell Mol Immunol.
Nov 3–2014.(Epub ahead of print).
|
|
26
|
Arababadi MK, Bidaki MZ and Kennedy D:
IL-17A in hepatitis B infection: friend or foe? Arch Virol.
159:1883–1888. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kimura A and Kishimoto T: IL-6: regulator
of Treg/Th17 balance. J Immunol. 40:1830–1835. 2010.
|
